Gotham Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,986
| Closed | -$232K | – | 1115 |
|
|
2020
Q4 | $232K | Buy |
+4,986
| New | +$232K | 0.01% | 896 |
|
|
2020
Q3 | – | Sell |
-5,304
| Closed | -$254K | – | 1155 |
|
|
2020
Q2 | $254K | Sell |
5,304
-19,996
| -79% | -$958K | 0.01% | 900 |
|
|
2020
Q1 | $1.16M | Sell |
25,300
-11,290
| -31% | -$519K | 0.03% | 516 |
|
|
2019
Q4 | $2.2M | Sell |
36,590
-6,178
| -14% | -$371K | 0.04% | 450 |
|
|
2019
Q3 | $2.42M | Buy |
42,768
+8,586
| +25% | +$486K | 0.04% | 422 |
|
|
2019
Q2 | $1.9M | Buy |
34,182
+12,550
| +58% | +$699K | 0.03% | 516 |
|
|
2019
Q1 | $1.09M | Buy |
21,632
+16,266
| +303% | +$821K | 0.02% | 637 |
|
|
2018
Q4 | $216K | Sell |
5,366
-4,837
| -47% | -$195K | ﹤0.01% | 923 |
|
|
2018
Q3 | $707K | Sell |
10,203
-4,166
| -29% | -$289K | 0.01% | 676 |
|
|
2018
Q2 | $1.09M | Sell |
14,369
-2,675
| -16% | -$202K | 0.02% | 580 |
|
|
2018
Q1 | $898K | Sell |
17,044
-35,197
| -67% | -$1.85M | 0.01% | 629 |
|
|
2017
Q4 | $2.79M | Sell |
52,241
-124,895
| -71% | -$6.67M | 0.04% | 439 |
|
|
2017
Q3 | $10.6M | Buy |
177,136
+1,922
| +1% | +$115K | 0.16% | 213 |
|
|
2017
Q2 | $13.8M | Buy |
175,214
+30,202
| +21% | +$2.38M | 0.19% | 169 |
|
|
2017
Q1 | $12M | Buy |
145,012
+57,583
| +66% | +$4.78M | 0.15% | 227 |
|
|
2016
Q4 | $6.94M | Buy |
87,429
+47,951
| +121% | +$3.8M | 0.09% | 316 |
|
|
2016
Q3 | $2.76M | Buy |
+39,478
| New | +$2.76M | 0.04% | 448 |
|
|
2015
Q3 | – | Sell |
-18,945
| Closed | -$1.53M | – | 1064 |
|
|
2015
Q2 | $1.53M | Buy |
+18,945
| New | +$1.53M | 0.01% | 574 |
|